APBN Online

White Papers

Coronavirus (SARS-CoV-2)

APBN Rapid Brief White Paper 2019 Novel Coronavirus (SARS-CoV-2); Expected challenges and risks to blood safety

The 2019 novel coronavirus (SARS-CoV-2) which emerged in China presents a significant health threat in the Asia-Pacific region, and the ability to impact blood supply through donor deferrals, illness, quarantine and reduced staff or donor availability.

This paper outlines key challenges and risks to assist blood sector preparedness, response and implementation of appropriate risk reduction strategies.


APBN White Paper Dengue and the Blood Supply (updated 2019)

This paper porvides an overview of the threats and challenges posed by Dengue to the safety and sufficiency of the blood supply in the Asia-Pacific region, and offers mitigation and risk management strategies for consideration by blood services operating in the region. This updated version of the paper also includes reference to;

  • vector control programs,
  • the now available dengue vaccine,     
  • reports of additional transfusion acquired dengue infections,
  • licensed RNA donor screening test availability, and
  • additional references.

APBN White Paper Dengue and the Blood Supply (2011)

In 2011, APBN prepared the APBN Dengue white paper to provide an overview of the threat posed by Dengue to the safety and sufficiency of the blood supply in the Asia-Pacific region and the challenges faced by blood services at that time.  It contains suggestions (relevant at the time of preparation) on how to mitigate the potential for transmission through blood transfusion, overviewed some of the measures that are available to reduce the risk to the blood supply and lists some thoughts on how blood services may approach selecting the most appropriate risk reduction strategy.


APBN Help Desk

If you have any questions or suggestions please contact us here.



<<  March 2023  >>
 Mo  Tu  We  Th  Fr  Sa  Su 
    1  2  3  4  5
  6  7  8  9101112
You are here: